Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Gadicke Ansbert
Relationship:   10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   30,197    

Indirect Shares

  56,162,356      
Direct Value   $22,204    

Indirect Value

  $184,466,517      
Total Shares   56,192,553      
Total Value   $184,488,721      


Allovir Inc
 $22,204 Allovir Inc
 $22,204
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    1    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -18.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Rigel Pharmaceuticals Inc RIGL Former 10% Owner 2004-07-02 0 2004-09-13 475,026    Premium*  
            Idenix Pharmaceuticals Inc IDIX Director, 10% Owner 2004-07-27 0 2004-07-27 4,797,991    Premium*  
            Radius Health Inc. RDUS Director 0 2016-09-27 3,887,502    Premium*  
            Pacira Pharmaceuticals, Inc. PCRX Former 10% Owner 0 2013-03-11 2,790,479    Premium*  
            Verastem, Inc. VSTM Director 2012-02-01 0 2012-02-01 3,740    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 2012-06-05 0 2012-07-09 1,275,886    Premium*  
            Epizyme, Inc. EPZM 10% Owner 0 2014-02-10 2,413,819    Premium*  
            Aratana Therapeutics, Inc. PETX 10% Owner 2014-03-07 0 2014-03-07 3,388,165    Premium*  
            Chiasma, Inc CHMA Director, 10% Owner 2015-07-21 0 2015-07-21 5,681,544    Premium*  
            Harpoon Therapeutics, Inc. HARP 10% Owner 2019-02-12 0 2019-02-12 8,422,847    Premium*  
            Tcr2 Therapeutics Inc. TCRR Director, 10% Owner 2019-02-19 0 2023-06-01 0    Premium*  
            Repare Therapeutics Inc. RPTX 10% Owner 2020-06-23 0 2021-07-12 3,882,485    Premium*  
            Allovir Inc ALVR Director, 10% Owner 2022-07-28 30,197 2022-07-28 16,674,766    Premium*  
            Dyne Therapeutics, Inc. DYN 10% Owner 2020-09-21 0 2020-09-21 91,081    Premium*  
            Oncorus, Inc. ONCR 10% Owner 0 2020-10-06 2,377,025    Premium*  
* Premium Members only  

Records found :    108         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-28 4 D $0.00 $0 I/I (1,499,989) 1,833,597 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-28 4 A $0.00 $0 I/I 16,203 1,849,800 -
VSTM Verastem, Inc. Director   –       •      –    2012-02-01 4 A $0.00 $0 I/I 1,933,333 1,933,333 0 -
RDUS Radius Health Inc. Director   –       •       •   2014-06-06 4 A $0.00 $0 I/I 5,831,253 2,141,547 0 -
ONCR Oncorus, Inc. 10% Owner   –       –       •   2020-10-06 4 A $0.00 $0 I/I 4,785,655 2,225,801 0 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2011-02-08 4/A A $0.00 $0 I/I 2,200,247 2,293,227 0 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2012-02-08 4 A $0.00 $0 I/I 2,200,247 2,293,227 0 -
ONCR Oncorus, Inc. 10% Owner   –       –       •   2020-10-06 4 B $15.00 $4,875,000 I/I 325,000 2,377,025 1.5 -
EPZM Epizyme, Inc. 10% Owner   –       –       •   2014-02-10 4 S $29.25 $13,649,981 I/I (466,666) 2,413,819 0 -
TCRR Tcr2 Therapeutics Inc. Director   –       •       •   2019-02-19 4 A $0.00 $0 I/I 5,852,612 2,704,315 0 -
PCRX Pacira Pharmaceuticals, I... Former 10% Owner   –       –      –    2013-03-11 4 S $27.86 $13,930,000 I/I (500,000) 2,790,479 0 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2011-02-08 4/A B $7.00 $3,749,998 I/I 535,714 2,828,941 1.5 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2012-02-08 4 B $7.00 $3,749,998 I/I 535,714 2,828,941 1.5 -
EPZM Epizyme, Inc. 10% Owner   –       –       •   2013-06-05 4 A $0.00 $0 I/I 2,702,154 2,880,485 0 -
SOMX Somaxon Pharmaceuticals, ... 10% Owner   –       –       •   2012-07-06 4 S $0.29 $195,324 I/I (671,217) 2,900,460 0 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2011-11-21 4 B $6.50 $2,999,997 I/I 461,538 3,290,479 1.5 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-28 4 S $15.83 $45,545 I/I (2,877) 3,333,586 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-25 4 S $15.80 $861,182 I/I (54,500) 3,336,463 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-24 4 S $15.54 $1,084,850 I/I (69,807) 3,390,963 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-23 4 S $15.50 $6,014 I/I (388) 3,460,770 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-22 4 S $15.51 $462,153 I/I (29,805) 3,461,158 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-02 4 S $18.00 $36,540 I/I (2,030) 3,490,963 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-01 4 S $17.95 $179,500 I/I (10,000) 3,492,993 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-05-28 4 S $18.00 $71,100 I/I (3,950) 3,502,993 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-05-27 4 S $17.85 $359,672 I/I (20,154) 3,506,943 -

  108  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed